ZA831387B - 1,2,4-triazine and pyrazine derivatives - Google Patents
1,2,4-triazine and pyrazine derivativesInfo
- Publication number
- ZA831387B ZA831387B ZA831387A ZA831387A ZA831387B ZA 831387 B ZA831387 B ZA 831387B ZA 831387 A ZA831387 A ZA 831387A ZA 831387 A ZA831387 A ZA 831387A ZA 831387 B ZA831387 B ZA 831387B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazine
- pyrazine derivatives
- gaba
- triazines
- diaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/354,982 US4513135A (en) | 1982-03-05 | 1982-03-05 | Diaryl-pyrazine derivatives affecting GABA binding |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA831387B true ZA831387B (en) | 1984-10-31 |
Family
ID=23395746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA831387A ZA831387B (en) | 1982-03-05 | 1983-03-01 | 1,2,4-triazine and pyrazine derivatives |
Country Status (22)
Country | Link |
---|---|
US (2) | US4513135A (xx) |
EP (1) | EP0088593B1 (xx) |
JP (1) | JPS58162582A (xx) |
KR (1) | KR860000847B1 (xx) |
AT (1) | ATE27457T1 (xx) |
AU (1) | AU547581B2 (xx) |
CA (1) | CA1195327A (xx) |
DD (1) | DD207716A5 (xx) |
DE (1) | DE3371786D1 (xx) |
DK (1) | DK97283A (xx) |
ES (2) | ES520340A0 (xx) |
FI (1) | FI830708L (xx) |
GB (1) | GB2116179B (xx) |
GR (1) | GR78459B (xx) |
HU (1) | HU191368B (xx) |
IL (1) | IL68002A (xx) |
NZ (1) | NZ203428A (xx) |
PH (1) | PH22535A (xx) |
PL (1) | PL240871A1 (xx) |
PT (1) | PT76312B (xx) |
RO (1) | RO86320B (xx) |
ZA (1) | ZA831387B (xx) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2567518B1 (fr) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent |
WO1992002513A1 (en) * | 1990-08-06 | 1992-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic compounds |
GB9420010D0 (en) * | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
DE69722426T3 (de) | 1996-07-24 | 2015-05-07 | Warner-Lambert Company LLC (n.Ges. des Staates Delaware) | Isobutylgaba und dessen derivate zur schmerzbehandlung |
TWI316055B (xx) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
KR100490893B1 (ko) * | 2002-10-11 | 2005-05-23 | (주) 비엔씨바이오팜 | 2-메톡시-1,3,5-트리아진 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
CA2596359A1 (en) * | 2005-02-01 | 2006-08-10 | Lake Erie Products | Anti-cross threading fastener |
AU2006236387A1 (en) * | 2005-04-18 | 2006-10-26 | Neurogen Corporation | Subtituted heteroaryl CB1 antagonists |
EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
CN102822150B (zh) | 2010-02-05 | 2014-12-03 | 赫普泰雅治疗有限公司 | 1,2,4-三嗪-4-胺衍生物 |
GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
TW201321353A (zh) * | 2011-10-08 | 2013-06-01 | Novartis Ag | 胺基甲酸酯/尿素衍生物 |
SG11201900157RA (en) | 2016-07-12 | 2019-02-27 | Revolution Medicines Inc | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
US11339135B2 (en) | 2016-11-30 | 2022-05-24 | Mitsubishi Tanabe Pharma Corporation | Method for producing triazine compound |
IL296456A (en) | 2017-01-23 | 2022-11-01 | Revolution Medicines Inc | Bicyclics as allosteric shp2 inhibitors |
AU2018210196B2 (en) | 2017-01-23 | 2022-06-02 | Revolution Medicines, Inc. | Pyridine compounds as allosteric SHP2 inhibitors |
SG11202001282UA (en) | 2017-09-07 | 2020-03-30 | Revolution Medicines Inc | Shp2 inhibitor compositions and methods for treating cancer |
MX2020003579A (es) | 2017-10-12 | 2020-07-22 | Revolution Medicines Inc | Compuestos de piridina, pirazina, y triazina como inhibidores de shp2 alostericos. |
RU2020123241A (ru) | 2017-12-15 | 2022-01-17 | Революшн Медсинз, Инк. | Полициклические соединения в качестве аллостерических ингибиторов shp2 |
IL278335B1 (en) | 2018-05-01 | 2024-05-01 | Revolution Medicines Inc | C26-linked rapamycin analogs as MTOR inhibitors |
PT3788049T (pt) | 2018-05-01 | 2023-06-07 | Revolution Medicines Inc | Análogos de rapamicina ligados ac40, c28 e c32 como inbidores de mtor |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172889A (en) * | 1965-03-09 | Process for the separation of z-methyl- | ||
US3294638A (en) * | 1961-06-05 | 1966-12-27 | Warner Lambert Pharmaceutical | Method and compositions employing 2-alkyl-3-piperidinopyrazines |
CH480795A (de) * | 1967-03-01 | 1969-11-15 | Sandoz Ag | Mittel zur Beeinflussung des Pflanzenwachstums |
US4013654A (en) * | 1974-01-31 | 1977-03-22 | Eli Lilly And Company | 5,6-diaryl-1,2,4-triazines |
US3989831A (en) * | 1974-01-31 | 1976-11-02 | Eli Lilly And Company | Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines |
US3979516A (en) * | 1974-01-31 | 1976-09-07 | Eli Lilly And Company | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines |
US3948894A (en) * | 1974-01-31 | 1976-04-06 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US4081542A (en) * | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
GB1493998A (en) * | 1975-06-03 | 1977-12-07 | Beecham Group Ltd | Propanolamine derivatives |
US4008232A (en) * | 1975-06-23 | 1977-02-15 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US4082844A (en) * | 1976-02-09 | 1978-04-04 | Merck & Co., Inc. | 6-chloro-2-(1-piperazinyl)pyrazine |
US4021553A (en) * | 1976-03-10 | 1977-05-03 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
US4190725A (en) * | 1976-03-10 | 1980-02-26 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines |
US4018923A (en) * | 1976-03-10 | 1977-04-19 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
NL7802514A (nl) * | 1977-03-09 | 1978-09-12 | Fabre Sa Pierre | 5,6-diaryl-1,2,4-triazinederivaten en werkwijze ter bereiding van deze verbindingen. |
CA1128507A (en) * | 1977-05-17 | 1982-07-27 | James M. Gullo | Pharmacologically active substituted 1,2,4-triazines |
US4251527A (en) * | 1977-05-17 | 1981-02-17 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
-
1982
- 1982-03-05 US US06/354,982 patent/US4513135A/en not_active Expired - Fee Related
-
1983
- 1983-02-28 IL IL68002A patent/IL68002A/xx unknown
- 1983-02-28 RO RO110181A patent/RO86320B/ro unknown
- 1983-02-28 DK DK97283A patent/DK97283A/da not_active Application Discontinuation
- 1983-03-01 PT PT76312A patent/PT76312B/pt unknown
- 1983-03-01 PH PH28587A patent/PH22535A/en unknown
- 1983-03-01 NZ NZ203428A patent/NZ203428A/en unknown
- 1983-03-01 ZA ZA831387A patent/ZA831387B/xx unknown
- 1983-03-02 FI FI830708A patent/FI830708L/fi not_active Application Discontinuation
- 1983-03-02 KR KR1019830000833A patent/KR860000847B1/ko active
- 1983-03-02 JP JP58035221A patent/JPS58162582A/ja active Pending
- 1983-03-03 EP EP83301142A patent/EP0088593B1/en not_active Expired
- 1983-03-03 GB GB08305846A patent/GB2116179B/en not_active Expired
- 1983-03-03 AU AU12029/83A patent/AU547581B2/en not_active Ceased
- 1983-03-03 CA CA000422805A patent/CA1195327A/en not_active Expired
- 1983-03-03 DE DE8383301142T patent/DE3371786D1/de not_active Expired
- 1983-03-03 AT AT83301142T patent/ATE27457T1/de not_active IP Right Cessation
- 1983-03-04 ES ES520340A patent/ES520340A0/es active Granted
- 1983-03-04 DD DD83248497A patent/DD207716A5/de unknown
- 1983-03-04 PL PL24087183A patent/PL240871A1/xx unknown
- 1983-03-04 GR GR70688A patent/GR78459B/el unknown
- 1983-03-04 HU HU83762A patent/HU191368B/hu unknown
- 1983-10-06 ES ES526297A patent/ES526297A0/es active Granted
-
1985
- 1985-01-04 US US06/688,946 patent/US4585861A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2116179B (en) | 1,2,4-triazine and pyrazine derivatives | |
ES8801546A1 (es) | Un procedimiento para la preparacion de compuesto de 2,2-difluoronucleosidos. | |
MX9700557A (es) | Dihidrobenzofuranos. | |
ES8606289A1 (es) | Un procedimiento para la preparacion de piridazinaminas. | |
AU1574483A (en) | Bismaleimide triazine composition | |
IE811431L (en) | Pyrazinyl oxadiazoles | |
ES8203375A1 (es) | Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras | |
BG45552A3 (bg) | Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони | |
EP0116628A4 (en) | 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE. | |
ES8507530A1 (es) | Un procedimiento para la preparacion de aricoxicicloalcanolaminolaminoalquilen-aril-cetonas. | |
SU1089968A1 (ru) | Магнитореологическая суспензия | |
PL252065A1 (en) | Method of obtaining 2,3,4,5-tetrahydro-1h-/1,4/diazepin /1,7-a/indoles | |
IT1170227B (it) | Caviglia per l'assemblaggio di parti di mobili | |
SU1256381A1 (ru) | Способ переработки редкоземельного концентрата | |
SU1083739A1 (ru) | Стокс-калибратор | |
SU1102116A2 (ru) | Реакционная камера | |
RO87212B1 (ro) | Derivati de p-fluorbenzamida | |
SU1111454A1 (ru) | Способ получения (4,6-дизамещенный пиримидинил-2)тиофанийбромидов | |
SU1122635A1 (ru) | Спеченный композиционный материал | |
SU1220308A1 (ru) | Производные дигидропирроло [1,2,3-e,d]пиримидо [4,5-b]пиразина или дигидропирроло [1,2,3-e,d]пиримидо[4,5-b]диазепина и способ их получения | |
SU1086938A1 (ru) | Способ голографической согласованной фильтрации | |
SU1217054A1 (ru) | Стокс-модулятор | |
SU1120886A1 (ru) | P-i-n-ДИОД | |
SU1114135A1 (ru) | Манотрон |